CCG1423 is primarily used in research settings to study cellular processes, particularly those involving the Rho signaling pathway. It is known to inhibit the serum response factor (SRF) mediated transcription, which plays a crucial role in cell proliferation, migration, and differentiation. Researchers utilize CCG1423 to explore its potential in controlling diseases characterized by abnormal cell growth, such as cancer and fibrosis. Additionally, it serves as a valuable tool in understanding the molecular mechanisms underlying cardiovascular diseases, as SRF is involved in the regulation of vascular smooth muscle cells. Its application in these areas helps in the development of targeted therapies and provides insights into the complex signaling networks within cells.